These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Towards structural systems pharmacology to study complex diseases and personalized medicine. Xie L; Ge X; Tan H; Xie L; Zhang Y; Hart T; Yang X; Bourne PE PLoS Comput Biol; 2014 May; 10(5):e1003554. PubMed ID: 24830652 [TBL] [Abstract][Full Text] [Related]
5. The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Ritchie MD Hum Genet; 2012 Oct; 131(10):1615-26. PubMed ID: 22923055 [TBL] [Abstract][Full Text] [Related]
6. The need to shift pharmacogenetic research from candidate gene to genome-wide association studies. Linskey DW; Linskey DC; McLeod HL; Luzum JA Pharmacogenomics; 2021 Nov; 22(17):1143-1150. PubMed ID: 34608812 [TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic Discovery Delineating the Genetic Basis of Drug Response. Zhang W; Zheng Y; Hou L Curr Genet Med Rep; 2013 Sep; 1(3):143-149. PubMed ID: 24015375 [TBL] [Abstract][Full Text] [Related]
9. Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation. Wheeler HE; Dolan ME Pharmacogenomics; 2012 Jan; 13(1):55-70. PubMed ID: 22176622 [TBL] [Abstract][Full Text] [Related]
10. Impact of the 1000 genomes project on the next wave of pharmacogenomic discovery. Zhang W; Dolan ME Pharmacogenomics; 2010 Feb; 11(2):249-56. PubMed ID: 20136363 [TBL] [Abstract][Full Text] [Related]
12. Variant discovery using next-generation sequencing and its future role in pharmacogenetics. Russell LE; Schwarz UI Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137 [TBL] [Abstract][Full Text] [Related]
13. The emerging era of pharmacogenomics: current successes, future potential, and challenges. Lee JW; Aminkeng F; Bhavsar AP; Shaw K; Carleton BC; Hayden MR; Ross CJ Clin Genet; 2014 Jul; 86(1):21-8. PubMed ID: 24684508 [TBL] [Abstract][Full Text] [Related]
14. Report on the 8th Annual Cold Spring Harbor/Wellcome Trust meeting on Pharmacogenomics and Personalized Medicine. Carr DF; Alfirevic A Pharmacogenomics; 2011 Mar; 12(3):315-7. PubMed ID: 21449671 [No Abstract] [Full Text] [Related]
15. Pharmacogenomics in clinical practice and drug development. Harper AR; Topol EJ Nat Biotechnol; 2012 Nov; 30(11):1117-24. PubMed ID: 23138311 [TBL] [Abstract][Full Text] [Related]
16. Progress towards the integration of pharmacogenomics in practice. Mooney SD Hum Genet; 2015 May; 134(5):459-65. PubMed ID: 25238897 [TBL] [Abstract][Full Text] [Related]
17. Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomics. Low SK; Takahashi A; Mushiroda T; Kubo M Clin Cancer Res; 2014 May; 20(10):2541-52. PubMed ID: 24831277 [TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics in the age of personalized medicine. Dickmann LJ; Ware JA Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics in the clinic. Relling MV; Evans WE Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045 [TBL] [Abstract][Full Text] [Related]
20. Evidence and resources to implement pharmacogenetic knowledge for precision medicine. Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]